BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Historical Holders from Q4 2019 to Q4 2025

Type / Class
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Symbol
BNTX on Nasdaq
Shares outstanding
239,647,920
Price per share
$95.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
50,457,110
Holdings value
$4,972,006,484
% of all portfolios
0.01%
Share change
-3,134,232
Value change
-$321,044,592
Average buys %
+0%
Average sells %
-0.01%
Number of holders
252
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Medine GmbH 18% $4,386,515,536 42,178,034 Prof. Ugur Sahin, M.D. 31 Mar 2025
As of 30 Sep 2025, BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) has 252 institutional shareholders filing 13F forms. They hold 50,457,110 shares of 239,647,920 outstanding shares (21%) .

Top 25 institutional shareholders own 18% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BAILLIE GIFFORD & CO 3.3% 7,879,359 -2% 0.58% $777,062,385
FMR LLC 2.3% 5,453,480 -33% 0.03% $537,822,188
T. Rowe Price Investment Management, Inc. 2% 4,833,642 +34% 0.29% $476,694,000
FLOSSBACH VON STORCH SE 1.8% 4,230,033 -0% 1.6% $417,165,854
PRIMECAP MANAGEMENT CO/CA/ 1.6% 3,870,766 -3.3% 0.29% $381,734,943
Dodge & Cox 1.5% 3,647,091 +316% 0.19% $359,676,114
Pfizer Inc 0.69% 1,658,361 -55% 37% $163,547,562
Temasek Holdings (Private) Ltd 0.63% 1,506,027 0% 0.52% $148,524,383
Capital International Investors 0.47% 1,135,066 +0.14% 0.02% $111,940,209
BNP PARIBAS FINANCIAL MARKETS 0.46% 1,103,298 0% 0.08% $108,807,249
BlackRock, Inc. 0.32% 765,309 -42% 0% $75,474,736
FRANKLIN RESOURCES INC 0.31% 732,816 -2.6% 0.02% $72,270,267
UBS Group AG 0.25% 607,440 +135% 0.01% $59,905,733
MORGAN STANLEY 0.25% 603,016 +4.9% 0% $59,469,525
Candriam S.C.A. 0.25% 589,452 +0.46% 0.31% $58,131,756
BANK OF AMERICA CORP /DE/ 0.24% 573,356 +344% 0% $56,544,369
Bank of New York Mellon Corp 0.24% 568,707 -49% 0.01% $56,085,873
DekaBank Deutsche Girozentrale 0.2% 481,397 0% 0.08% $47,230,000
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 0.19% 459,673 -6.6% 0.04% $45,301,241
VICTORY CAPITAL MANAGEMENT INC 0.17% 413,685 +97% 0.02% $37,530,850
Long Focus Capital Management, LLC 0.17% 397,655 +91% 2.3% $39,216,736
CITADEL ADVISORS LLC 0.16% 389,495 +14262% 0.03% $38,411,997
DEUTSCHE BANK AG\ 0.16% 382,476 +11% 0.01% $37,719,784
BAKER BROS. ADVISORS LP 0.15% 368,923 0% 0.26% $36,383,186
LBP AM SA 0.15% 353,329 +16% 0.43% $34,845,306

Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 398,125 $37,901,798 +$32,836,993 $95.20 4
2025 Q3 50,457,110 $4,972,006,484 -$321,044,592 $98.62 252
2025 Q2 53,756,637 $5,723,405,583 +$241,986,249 $106.47 255
2025 Q1 51,766,102 $4,713,883,792 +$16,375,983 $91.06 276
2024 Q4 50,762,221 $5,785,970,647 +$270,315,091 $113.95 299
2024 Q3 44,146,673 $5,240,957,854 +$448,042,220 $118.77 288
2024 Q2 40,965,872 $3,292,084,415 -$3,371,001 $80.36 278
2024 Q1 40,861,236 $3,768,152,227 +$21,661,779 $92.25 278
2023 Q4 40,542,745 $4,273,885,983 +$369,420,974 $105.54 277
2023 Q3 36,919,967 $4,008,689,944 -$40,677,233 $108.64 245
2023 Q2 37,381,433 $4,042,183,779 -$207,319,966 $107.93 246
2023 Q1 39,079,137 $4,865,003,807 -$130,605,071 $124.57 272
2022 Q4 39,706,670 $5,966,384,929 +$387,882,980 $150.22 312
2022 Q3 37,131,368 $5,008,892,299 +$489,942,648 $134.88 249
2022 Q2 33,416,255 $4,980,080,985 -$212,346,370 $149.10 276
2022 Q1 34,519,697 $5,890,695,868 -$225,320,254 $170.56 274
2021 Q4 35,195,775 $9,066,882,359 -$433,429,701 $257.80 334
2021 Q3 36,667,998 $10,011,251,135 +$781,975,407 $272.99 328
2021 Q2 33,709,299 $7,548,281,316 +$1,380,454,495 $223.88 275
2021 Q1 29,716,757 $3,242,039,601 +$922,839,812 $109.19 213
2020 Q4 20,695,182 $1,688,417,367 -$282,174,671 $81.52 183
2020 Q3 24,274,421 $1,679,824,791 -$160,429,955 $69.23 144
2020 Q2 26,613,030 $1,776,088,789 +$1,335,873,540 $66.74 108
2020 Q1 6,620,182 $383,744,138 -$108,916,451 $58.40 36
2019 Q4 8,476,761 $285,550,000 +$285,550,000 $33.88 19